Neuropn Therapeutics presents bifunctional epoxide hydrolase 2 inhibitors for Parkinson's disease | BioWorld

2022-11-15 08:51:19 By : Ms. Alice Gao

All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy. Tipiracil Intermediate Manufacturer

Neuropn Therapeutics presents bifunctional epoxide hydrolase 2 inhibitors for Parkinson's disease | BioWorld

Subscribe to BioWorld™ news services

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Neuropn Therapeutics presents bifunctional epoxide hydrolase 2 inhibitors for Parkinson's disease | BioWorld

Nmn Supplement Powder Copyright ©2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing